Please assess the completion status of the following clinical trial:

Trial Title: IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age: \> or equal to 18 years and \< or equal to 85 years~* Documented ischemia with Rutherford classification 2, 3, or 4~* Target lesion in the SFA and/or PPA~* Angiographic evidence that target lesion consists of a single de novo or non-stented restenotic lesion or is a combination lesion that meets the following criteria:~  1. 70 - 99% occlusion by visual estimate with lesion length \> or equal to 4 cm and \< or equal to 18 cm~ 2. 100% occlusion by visual estimate with lesion length \< or equal to 10 cm~ 3. Combination lesions must have a total lesion length of \> or equal to 4 cm and \< or equal to 18 cm with an occluded segment that is \< or equal to 10 cm (by visual estimate)~* Target vessel diameter \> or equal to 4 mm and \< or equal to 7 mm~* Angiographic evidence of adequate distal run-off to the ankle~* Able to walk without assistive devices~Exclusion Criteria:~* Stroke or heart attack within 3 months prior to enrollment~* Enrolled in another investigational drug, device or biologic study~* Any surgical procedure or intervention performed within 30 days prior to or post index procedure~* SFA or PPA disease in the opposite leg that requires treatment at the index procedure~* Failure to successfully cross the target lesion~* Angiographic evidence of severe calcification~* Target lesion requires treatment with alternative therapies such as stenting, laser, atherectomy, cryoplasty, brachytherapy, re-entry devices)~* Known allergies or sensitivity to heparin, aspirin, other anticoagulant/antiplatelet therapies, paclitaxel or contrast media that cannot be adequately pre-treated prior to index procedure~* Chronic kidney disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Drug-Coated Balloon (DCB) (Type: EXPERIMENTAL): IN.PACT Admiral: Balloon Angioplasty
- Standard PTA (Type: ACTIVE_COMPARATOR): Standard Percutaneous Balloon Angioplasty (PTA) Balloon: Balloon Angioplasty

Based on this trial design, predict the completion outcome and termination type (if applicable).